The All Star Team of Amgen Losers!

[anonymous]

https://www.amgenbd.com/meet-the-team/

 

[anonymous]

they wrote the book on picking and overpaying for shitty drugs.

 

[anonymous]

helen kim....what was sasha thinking ?

 

[anonymous]

What do these people do ?

 

[anonymous]

What do these people do ?

They are professional window shoppers. Amgen has money to buy but these people fucked up M&A over the last 10 years that all they do now is look at things and find reasons to not do a deal. No one wants to be accountable.

 

[anonymous]

they pay McKinsey along with the strategy group to do tons of worthless projects

 

[anonymous]

They use consultants as a crutch while they go on endless travel junkets and suck at the corporate teat.

 

[anonymous]

I’ve known people who were in Amgen BD in the Sharer era and they were great and moved on to bigger/better things. This current group is a joke. Relying on strategy consultants for BD instead of docs/scientists is a recipe for analysis paralysis.

 

[anonymous]

I’ve known people who were in Amgen BD in the Sharer era and they were great and moved on to bigger/better things. This current group is a joke. Relying on strategy consultants for BD instead of docs/scientists is a recipe for analysis paralysis.

McKinsey consultants are better drug developers than people who actually do it for a living

 

[anonymous]

Jay Stamatis left Amgen and is now head of Abbvie BD.

 

[anonymous]

When all you do is hire the Jay Chiangs of the world, you know you are pretty worthless and stupid.

 

[anonymous]

I’ve known people who were in Amgen BD in the Sharer era and they were great and moved on to bigger/better things. This current group is a joke. Relying on strategy consultants for BD instead of docs/scientists is a recipe for analysis paralysis.

Especially if you consider swindling BMY out of $300 M for a useless drug lead going on to “bigger and better” things.

 

[anonymous]

I’ve known people who were in Amgen BD in the Sharer era and they were great and moved on to bigger/better things. This current group is a joke. Relying on strategy consultants for BD instead of docs/scientists is a recipe for analysis paralysis.

Hiring Sharer was the beginning of the end for Amgen. It hasn't been the same since.